Day: July 17, 2023

Advanced Emissions Solutions Announces CEO Transition

Written by Customer Service on July 17, 2023. Posted in Public Companies.

Board has appointed Robert Rasmus as next Chief Executive Officer effective July 17, 2023 GREENWOOD VILLAGE, Colo., July 17, 2023 (GLOBE NEWSWIRE) — Advanced Emissions Solutions, Inc. (NASDAQ: ADES) (the “Company” or “ADES”), a leader in emissions control solutions for power generation, industrial and municipal water purification markets, today announced that Mr. Robert “Bob” Rasmus has been appointed to succeed Greg Marken as the Company’s President and Chief Executive Officer on July 17, 2023. L. Spencer Wells, Chairman of the Board, commented, “On behalf of the entire Board of Directors, I want to thank Greg for his service to the Company and his leadership for the past three years. Greg took over as CEO during an uncertain time at the height of the COVID-19 pandemic, and immediately...

Acumen Pharmaceuticals Announces Proposed Public Offering of Common Stock

Written by Customer Service on July 17, 2023. Posted in Public Companies.

CHARLOTTESVILLE, Va. and CARMEL, Ind., July 17, 2023 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s disease (AD), today announced that it has commenced an underwritten public offering of $100 million of shares of its common stock. All of the shares to be sold in the offering are to be sold by Acumen. In connection with the offering, Acumen intends to grant the underwriters a 30-day option to purchase up to an additional $15 million of shares of its common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. BofA Securities,...

ETC Announces Fiscal 2024 First Quarter Results

Written by Customer Service on July 17, 2023. Posted in Earnings Releases And Operating Results.

SOUTHAMPTON, Pa., July 17, 2023 (GLOBE NEWSWIRE) — Environmental Tectonics Corporation (OTC Pink: ETCC) (“ETC” or the “Company”) today reported its financial results for the thirteen week period ended May 26, 2023 (the “2024 first fiscal quarter”). Robert L. Laurent, Jr., ETC’s Chief Executive Officer and President stated, “We are pleased with the 31% increase in ETC sales vs. prior year driven by a 77% increase in sales vs. prior year within our Sterilizers business and a 108% increase in sales of Aeromedical Training Solutions products vs. prior year. ETC finished the quarter with a backlog of approximately $100 million, which we anticipate driving increases in production, sales and profitability.” Fiscal 2024 First Quarter Results of Operations Net Income (Loss) Attributable to ETC Net loss attributable to ETC was $1.1 million,...

Legacy Lithium Announces Proposed Sale of Green Energy Project

Written by Customer Service on July 17, 2023. Posted in Mergers And Acquisitions.

CALGARY, Alberta, July 17, 2023 (GLOBE NEWSWIRE) — Legacy Lithium Corp. (the “Company” or “Legacy”) is pleased to announce that its wholly-owned subsidiary, Legacy Lithium (Utah) LLC (the “Subsidiary”) has entered into a definitive agreement to sell 100% of its interest in the mineral properties comprising the Green Energy Project, located in Grand County, Utah (the “Property”) (the “Transaction”). The Subsidiary is selling its interest in the Green Energy Project to Anson Resources Limited (ASX:ASN) (“Anson”) in exchange for USD$1,000,000 in cash, 15,060,981 Anson common shares (the “Consideration Shares”), and reimbursement of certain fees and costs payable to the Bureau of Land Management in connection with the Property. One-eighth (1/8) of the Consideration Shares will be issued on closing of the Transaction (“Closing”), with...

GIG Public Warrant Exercise Announcement

Written by Customer Service on July 17, 2023. Posted in Public Companies.

Please refer to the attached press release in respect of the GIG Public Warrant Announcement. Attachment20230717 Warrant Exercise – Kari Stadigh – final

Vertex to Announce Second Quarter 2023 Financial Results on Wednesday, August 9, 2023

Written by Customer Service on July 17, 2023. Posted in Public Companies.

KING OF PRUSSIA, Pa., July 17, 2023 (GLOBE NEWSWIRE) — Vertex, Inc. (NASDAQ:VERX), a leading global technology provider of indirect tax solutions, today announced that it will release second quarter 2023 financial results before the market opens on Wednesday, August 9, 2023. A conference call to discuss the results will be held at 8:30 a.m. Eastern Time that same day. Those wishing to participate may do so by dialing 1-201-689-8471 approximately ten minutes prior to start time. A listen-only webcast of the call will also be available through the Company’s Investor Relations website at https://ir.vertexinc.com. A conference call replay will be available approximately one hour after the call by dialing 1-412-317-6671 and referencing passcode 13739853, or via the Company’s Investor Relations website. The replay will expire on August...

Clearmind Medicine Announces Share-Based Payment for the Company’s Consultants

Written by Customer Service on July 17, 2023. Posted in Public Companies.

Tel Aviv, Israel / Vancouver, Canada, July 17, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the “company”), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, today announced that it has issued 17,899 common shares in the capital of the Company (“Shares”) in lieu of the final payment of $10,000, starting May 1st 2022, to consultants of the Company. In addition, the Company has issued restricted stock units (“RSUS”) for additional consultant in lieu of payment of $5,000. All Shares will only be subjected to those restrictions designated in applicable securities laws. About Clearmind Medicine Inc. Clearmind is a psychedelic pharmaceutical biotech company...

CrossAmerica Partners to Announce Second Quarter 2023 Earnings Results on August 7

Written by Customer Service on July 17, 2023. Posted in Public Companies.

Allentown, PA, July 17, 2023 (GLOBE NEWSWIRE) — CrossAmerica Partners to Announce Second Quarter 2023 Earnings Results on August 7 ALLENTOWN, PA, July 17, 2023 – CrossAmerica Partners LP (NYSE: CAPL) today announced that it will release its second quarter 2023 results after the market closes on Monday, August 7, 2023. In conjunction with the news release, management will host a conference call on Tuesday, August 8 at 9:00 a.m. Eastern Time. The conference call numbers are 888-396-8049 or 416-764-8646 and the passcode for both is 70854269. A live audio webcast of the conference call and the related earnings materials, including reconciliations of any non-GAAP financial measures to GAAP financial measures and any other applicable disclosures, will be available on that same day on the investor section of the CrossAmerica website...

Berry Corporation Announces Acquisition of Macpherson Energy Corporation

Written by Customer Service on July 17, 2023. Posted in Mergers And Acquisitions.

Attractively Priced Acquisition of Oil Producing Assets Reflects Disciplined Capital Returns Strategy to Deliver Enhanced Free Cash Flow DALLAS, July 17, 2023 (GLOBE NEWSWIRE) — Berry Corporation (bry) (NASDAQ: BRY) (“Berry” or the “Company”) announced today that it has executed a definitive agreement to acquire Macpherson Energy Corporation, a privately held Kern County, California operator, for $70 million in cash, subject to customary purchase price adjustments. The transaction is structured such that $50 million will be paid at closing and the remainder paid in July 2024. This is a value creating transaction for Berry and our shareholders that we expect to be fully paid for by mid-year 2024 based on current projections for the pro forma company and $75/barrel Brent pricing. Substantially all of the purchase price will come...

Royalty Pharma Declares Third Quarter 2023 Dividend

Written by Customer Service on July 17, 2023. Posted in Dividend Reports And Estimates.

NEW YORK, July 17, 2023 (GLOBE NEWSWIRE) — The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2023 of $0.20 per Class A ordinary share. The dividend will be paid on September 15, 2023, to shareholders of record at the close of business on August 18, 2023. About Royalty Pharma Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry’s...

Day: July 17, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals